Codon AG (STU:CNW) Operating Margin %: -325.29% (As of Jun. 2022)


STU:CNW Codon AG STU:CNW
4 GF Score
Price €0.02
View Full Analysis

What is Codon AG Operating Margin %?

Codon AG STU:CNW +2.94% 4 Operating Margin % is -325.29% as of Jun. 2022. GuruFocus rates STU:CNW with a GF Score™ of 4/100.

Operating Margin % is calculated as Operating Income divided by its Revenue. Codon AG's Operating Income for the six months ended in Jun. 2022 was €-10.60 Mil. Codon AG's Revenue for the six months ended in Jun. 2022 was €3.26 Mil. Therefore, Codon AG's Operating Margin % for the quarter that ended in Jun. 2022 was -325.29%.

The historical rank and industry rank for Codon AG's Operating Margin % or its related term are showing as below:


STU:CNW's Operating Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -86.77
* Ranked among companies with meaningful Operating Margin % only.

Codon AG's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Codon AG's Operating Income for the six months ended in Jun. 2022 was €-10.60 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2022 was €-13.21 Mil.


Codon AG  (STU:CNW) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Codon AG Operating Margin % Related Terms


Codon AG Operating Margin % Historical Data

* Premium members only.

The historical data trend for Codon AG's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Codon AG Operating Margin % Chart

Codon AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -101.79 -151.41 -137.79 -161.70 -85.96

Codon AG Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -210.04 -122.31 -180.44 -39.73 -325.29

STU:CNW vs VRTX, REGN, SGEN: Operating Margin % Comparison

For the Biotechnology subindustry, Codon AG's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Codon AG Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Codon AG's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Codon AG's Operating Margin % falls into.


STU:CNW
4GF Score
Codon AG STU:CNW
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Codon AG Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Codon AG's Operating Margin % for the fiscal year that ended in Dec. 2021 is calculated as

Operating Margin %=Operating Income (A: Dec. 2021 ) / Revenue (A: Dec. 2021 )
=-8.427 / 9.803
=-85.96 %

Codon AG's Operating Margin % for the quarter that ended in Jun. 2022 is calculated as

Operating Margin %=Operating Income (Q: Jun. 2022 ) / Revenue (Q: Jun. 2022 )
=-10.598 / 3.258
=-325.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -325.29% mean?
Codon AG (STU:CNW) has a Operating Margin % of -325.29% as of Jun. 2022. Operating margin is the ratio of total operating income to net sales. View historical data on Codon AG and its competitors.
Is Codon AG's Operating Margin % too high?
Codon AG's current Operating Margin % is -325.29%. Overall, Codon AG has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Codon AG's Operating Margin % compare to VRTX and REGN?
Codon AG's Operating Margin % of -325.29% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Codon AG and its competitors. Codon AG's current Operating Margin % is -325.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Codon AG stock overvalued right now?
Codon AG (STU:CNW) has a current Operating Margin % of -325.29%. The current Operating Margin % is -325.29%. Codon AG's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Codon AG (STU:CNW), the current Operating Margin % is -325.29% as of Jun. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Codon AG Business Description

Address Warthestrasse 21, Teltow, DEU, 14513
Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.
4GF Score

Get the complete analysis for STU:CNW

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price